Logo image of ICHR

ICHOR HOLDINGS LTD (ICHR) Stock Fundamental Analysis

USA - Nasdaq - NASDAQ:ICHR - KYG4740B1059 - Common Stock

18.55 USD
+0.18 (+0.98%)
Last: 12/23/2025, 8:11:40 PM
18.54 USD
-0.01 (-0.05%)
After Hours: 12/23/2025, 8:11:40 PM
Fundamental Rating

3

Overall ICHR gets a fundamental rating of 3 out of 10. We evaluated ICHR against 113 industry peers in the Semiconductors & Semiconductor Equipment industry. ICHR may be in some trouble as it scores bad on both profitability and health. ICHR is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

In the past year ICHR was profitable.
ICHR had a positive operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: ICHR reported negative net income in multiple years.
ICHR had a positive operating cash flow in each of the past 5 years.
ICHR Yearly Net Income VS EBIT VS OCF VS FCFICHR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M 40M -40M 60M 80M

1.2 Ratios

Looking at the Return On Assets, with a value of -4.22%, ICHR is doing worse than 64.60% of the companies in the same industry.
The Return On Equity of ICHR (-6.03%) is worse than 63.72% of its industry peers.
Industry RankSector Rank
ROA -4.22%
ROE -6.03%
ROIC N/A
ROA(3y)0.02%
ROA(5y)2.26%
ROE(3y)0.6%
ROE(5y)4.81%
ROIC(3y)N/A
ROIC(5y)N/A
ICHR Yearly ROA, ROE, ROICICHR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 20 -20

1.3 Margins

With a Gross Margin value of 9.80%, ICHR is not doing good in the industry: 85.84% of the companies in the same industry are doing better.
ICHR's Gross Margin has declined in the last couple of years.
ICHR does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 9.8%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-9.35%
GM growth 5Y-2.65%
ICHR Yearly Profit, Operating, Gross MarginsICHR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 -5 10 15

3

2. Health

2.1 Basic Checks

ICHR does not have a ROIC to compare to the WACC, probably because it is not profitable.
ICHR has more shares outstanding than it did 1 year ago.
ICHR has more shares outstanding than it did 5 years ago.
ICHR has a better debt/assets ratio than last year.
ICHR Yearly Shares OutstandingICHR Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M
ICHR Yearly Total Debt VS Total AssetsICHR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

2.2 Solvency

An Altman-Z score of 2.77 indicates that ICHR is not a great score, but indicates only limited risk for bankruptcy at the moment.
ICHR has a Altman-Z score (2.77) which is comparable to the rest of the industry.
A Debt/Equity ratio of 0.17 indicates that ICHR is not too dependend on debt financing.
With a Debt to Equity ratio value of 0.17, ICHR perfoms like the industry average, outperforming 49.56% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.17
Debt/FCF N/A
Altman-Z 2.77
ROIC/WACCN/A
WACC10.56%
ICHR Yearly LT Debt VS Equity VS FCFICHR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M 600M

2.3 Liquidity

A Current Ratio of 3.08 indicates that ICHR has no problem at all paying its short term obligations.
The Current ratio of ICHR (3.08) is comparable to the rest of the industry.
A Quick Ratio of 1.33 indicates that ICHR should not have too much problems paying its short term obligations.
ICHR has a Quick ratio of 1.33. This is in the lower half of the industry: ICHR underperforms 77.88% of its industry peers.
Industry RankSector Rank
Current Ratio 3.08
Quick Ratio 1.33
ICHR Yearly Current Assets VS Current LiabilitesICHR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M 500M

6

3. Growth

3.1 Past

ICHR shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 1400.00%, which is quite impressive.
ICHR shows a very negative growth in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -33.82% yearly.
Looking at the last year, ICHR shows a quite strong growth in Revenue. The Revenue has grown by 16.86% in the last year.
ICHR shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 6.46% yearly.
EPS 1Y (TTM)1400%
EPS 3Y-63.79%
EPS 5Y-33.82%
EPS Q2Q%-41.67%
Revenue 1Y (TTM)16.86%
Revenue growth 3Y-8.18%
Revenue growth 5Y6.46%
Sales Q2Q%13.34%

3.2 Future

Based on estimates for the next years, ICHR will show a very strong growth in Earnings Per Share. The EPS will grow by 73.41% on average per year.
ICHR is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 10.33% yearly.
EPS Next Y27.95%
EPS Next 2Y127%
EPS Next 3Y112.98%
EPS Next 5Y73.41%
Revenue Next Year11.5%
Revenue Next 2Y8.4%
Revenue Next 3Y8.88%
Revenue Next 5Y10.33%

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
ICHR Yearly Revenue VS EstimatesICHR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 500M 1B
ICHR Yearly EPS VS EstimatesICHR Yearly EPS VS EstimatesYearly EPS VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 1 2 3

2

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 61.83, the valuation of ICHR can be described as expensive.
The rest of the industry has a similar Price/Earnings ratio as ICHR.
The average S&P500 Price/Earnings ratio is at 26.50. ICHR is valued rather expensively when compared to this.
Based on the Price/Forward Earnings ratio of 22.50, the valuation of ICHR can be described as rather expensive.
Based on the Price/Forward Earnings ratio, ICHR is valued a bit cheaper than 78.76% of the companies in the same industry.
ICHR's Price/Forward Earnings ratio indicates a similar valuation than the S&P500 average which is at 23.93.
Industry RankSector Rank
PE 61.83
Fwd PE 22.5
ICHR Price Earnings VS Forward Price EarningsICHR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of ICHR is on the same level as its industry peers.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 139.53
ICHR Per share dataICHR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15 20 25

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates ICHR does not grow enough to justify the current Price/Earnings ratio.
ICHR's earnings are expected to grow with 112.97% in the coming years. This may justify a more expensive valuation.
PEG (NY)2.21
PEG (5Y)N/A
EPS Next 2Y127%
EPS Next 3Y112.98%

0

5. Dividend

5.1 Amount

No dividends for ICHR!.
Industry RankSector Rank
Dividend Yield 0%

ICHOR HOLDINGS LTD

NASDAQ:ICHR (12/23/2025, 8:11:40 PM)

After market: 18.54 -0.01 (-0.05%)

18.55

+0.18 (+0.98%)

Chartmill FA Rating
GICS IndustryGroupSemiconductors & Semiconductor Equipment
GICS IndustrySemiconductors & Semiconductor Equipment
Earnings (Last)11-03 2025-11-03/amc
Earnings (Next)02-02 2026-02-02/amc
Inst Owners98.22%
Inst Owner Change-5.46%
Ins Owners1.5%
Ins Owner Change21.12%
Market Cap637.75M
Revenue(TTM)957.34M
Net Income(TTM)-40.76M
Analysts78.46
Price Target24.31 (31.05%)
Short Float %10.19%
Short Ratio3.94
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-60.69%
Min EPS beat(2)-79.27%
Max EPS beat(2)-42.12%
EPS beat(4)0
Avg EPS beat(4)-46.48%
Min EPS beat(4)-79.27%
Max EPS beat(4)-9.51%
EPS beat(8)2
Avg EPS beat(8)-601.07%
EPS beat(12)4
Avg EPS beat(12)-374.76%
EPS beat(16)6
Avg EPS beat(16)-280.24%
Revenue beat(2)1
Avg Revenue beat(2)0.11%
Min Revenue beat(2)-0.23%
Max Revenue beat(2)0.45%
Revenue beat(4)1
Avg Revenue beat(4)-0.92%
Min Revenue beat(4)-2.16%
Max Revenue beat(4)0.45%
Revenue beat(8)4
Avg Revenue beat(8)-0.16%
Revenue beat(12)6
Avg Revenue beat(12)-0.3%
Revenue beat(16)8
Avg Revenue beat(16)-0.27%
PT rev (1m)-4.03%
PT rev (3m)-1.38%
EPS NQ rev (1m)-2269.14%
EPS NQ rev (3m)-143.8%
EPS NY rev (1m)-50.24%
EPS NY rev (3m)-55.01%
Revenue NQ rev (1m)-0.9%
Revenue NQ rev (3m)-5.87%
Revenue NY rev (1m)-0.86%
Revenue NY rev (3m)-0.86%
Valuation
Industry RankSector Rank
PE 61.83
Fwd PE 22.5
P/S 0.67
P/FCF N/A
P/OCF 34.99
P/B 0.94
P/tB 2.14
EV/EBITDA 139.53
EPS(TTM)0.3
EY1.62%
EPS(NY)0.82
Fwd EY4.44%
FCF(TTM)-0.56
FCFYN/A
OCF(TTM)0.53
OCFY2.86%
SpS27.85
BVpS19.67
TBVpS8.68
PEG (NY)2.21
PEG (5Y)N/A
Graham Number11.52
Profitability
Industry RankSector Rank
ROA -4.22%
ROE -6.03%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 9.8%
FCFM N/A
ROA(3y)0.02%
ROA(5y)2.26%
ROE(3y)0.6%
ROE(5y)4.81%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-9.35%
GM growth 5Y-2.65%
F-Score4
Asset Turnover0.99
Health
Industry RankSector Rank
Debt/Equity 0.17
Debt/FCF N/A
Debt/EBITDA 24.68
Cap/Depr 118.71%
Cap/Sales 3.9%
Interest Coverage N/A
Cash Conversion 383.91%
Profit Quality N/A
Current Ratio 3.08
Quick Ratio 1.33
Altman-Z 2.77
F-Score4
WACC10.56%
ROIC/WACCN/A
Cap/Depr(3y)62.01%
Cap/Depr(5y)61.74%
Cap/Sales(3y)2.1%
Cap/Sales(5y)1.86%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)1400%
EPS 3Y-63.79%
EPS 5Y-33.82%
EPS Q2Q%-41.67%
EPS Next Y27.95%
EPS Next 2Y127%
EPS Next 3Y112.98%
EPS Next 5Y73.41%
Revenue 1Y (TTM)16.86%
Revenue growth 3Y-8.18%
Revenue growth 5Y6.46%
Sales Q2Q%13.34%
Revenue Next Year11.5%
Revenue Next 2Y8.4%
Revenue Next 3Y8.88%
Revenue Next 5Y10.33%
EBIT growth 1Y-86.02%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year211.09%
EBIT Next 3Y69.58%
EBIT Next 5Y50.15%
FCF growth 1Y-149.43%
FCF growth 3YN/A
FCF growth 5Y-22.51%
OCF growth 1Y-69.02%
OCF growth 3Y22.22%
OCF growth 5Y-13.37%

ICHOR HOLDINGS LTD / ICHR FAQ

What is the ChartMill fundamental rating of ICHOR HOLDINGS LTD (ICHR) stock?

ChartMill assigns a fundamental rating of 3 / 10 to ICHR.


What is the valuation status of ICHOR HOLDINGS LTD (ICHR) stock?

ChartMill assigns a valuation rating of 2 / 10 to ICHOR HOLDINGS LTD (ICHR). This can be considered as Overvalued.


How profitable is ICHOR HOLDINGS LTD (ICHR) stock?

ICHOR HOLDINGS LTD (ICHR) has a profitability rating of 2 / 10.


What is the valuation of ICHOR HOLDINGS LTD based on its PE and PB ratios?

The Price/Earnings (PE) ratio for ICHOR HOLDINGS LTD (ICHR) is 61.83 and the Price/Book (PB) ratio is 0.94.


Can you provide the expected EPS growth for ICHR stock?

The Earnings per Share (EPS) of ICHOR HOLDINGS LTD (ICHR) is expected to grow by 27.95% in the next year.